Continued research and clinical experience will shed light on the definitiveness of this therapy, including its long-term effects. Until then, MPA for this use should be considered experimental treatment involving complex legal and ethical issues, and it should be considered only in cases of problematic or unresponsive patients. For this patient, the consultant pharmacist recommended continuance of cognitive-behavioral treatment, since his mental faculties were intact. Only if his behavior becomes intolerable or dangerous should this treatment be considered. The University of Arizona Tucson, AZ 85721 References 1.
Medroxyprogesterone acetate as a treatment for sexual acting out in organic brain syndrome.
Pharmacotherapy of sexual offenders. Gagne P. Treatment of sex offenders with medroxyprogesterone acetate. Intramuscular medroxyprogesterone acetate for sexual aggression in elderly men. Behavioral problems manifest as inappropriate sexual remarks and behaviors. He has continuing problems of sexual inappropriateness, including refusal to wear clothing, public masturbation, grabbing women staff members, attempts at kissing, sexual remarks, and exposing himself.